Skip to main content
Caplight Logo









Linno Pharmaceuticals Inc.

Linno Pharmaceuticals Inc.

Private
ShanghaiHealthcare & Life Scienceshttps://linnopharma.com/

Last Round

Early Funding

Jul 18, 2022

Company Overview

Linno Pharmaceuticals Inc. is a biopharmaceutical company that develops therapies for severe, rare, and chronic diseases using its proprietary blood-brain barrier-penetrating drug delivery technology and next-generation complement inhibitors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

blood-brain barrier deliverycomplement inhibitordrug delivery platformrare disease therapyclinical-stage biotechorphan drugBBB deliverypathway-selective complement inhibitorIgA NephropathyIgANenzyme replacement therapylysosomal storage disorderKrabbe diseaseMetachromatic Leukodystrophyorphan drug designationODDbi-specific antibody

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Linno Pharmaceuticals Inc. Comparables

Compare Linno Pharmaceuticals Inc. with similar companies based on industry and business-model similarity.

Linno Pharmaceuticals Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Omeros Corporation
74%
JCR Pharmaceuticals Co., Ltd.
73%
Novartis
72%

Linno Pharmaceuticals Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJul 18, 2022
AngelNov 19, 2019

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2022

    Completed an early funding round.

  • Nov 19, 2019

    Completed an angel funding round.

Linno Pharmaceuticals Inc. Filings

Explore SEC and related filing metadata, where available.

Linno Pharmaceuticals Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Linno Pharmaceuticals Inc.'s valuation, stock price, and market status.

Is Linno Pharmaceuticals Inc. a public or private company?

Linno Pharmaceuticals Inc. is a private company.

What is the current stock price of Linno Pharmaceuticals Inc.?

Linno Pharmaceuticals Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Linno Pharmaceuticals Inc. worth (valuation)?

Valuation information for Linno Pharmaceuticals Inc. is not publicly available.

Can I buy Linno Pharmaceuticals Inc. stock?

Linno Pharmaceuticals Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Linno Pharmaceuticals Inc.'s last funding round?

Funding round information for Linno Pharmaceuticals Inc. is not publicly available.

Who are the main investors in Linno Pharmaceuticals Inc.?

Investor information for Linno Pharmaceuticals Inc. is not publicly disclosed.

Will Linno Pharmaceuticals Inc. IPO soon?

No public IPO plans have been announced for Linno Pharmaceuticals Inc..

How can I track Linno Pharmaceuticals Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Linno Pharmaceuticals Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Year Founded2019
Last FundingJul 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?